Krista Marie Schenkel, D,O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 44 East Avenue, Strausstown, PA 19559 Phone: 610-488-7080 Fax: 610-488-7019 |
News Archive
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.
A new study, published online April 8 by Cell Press in the journal Immunity, describes a unique therapeutic "nanovaccine" that successfully reverses diabetes in a mouse model of the disease. In addition to providing new insight into diabetes, the research also reveals an aspect of the pathogenesis of the autoimmune response that may provide a therapeutic strategy for multiple autoimmune disorders.
The Pittsburgh Post-Gazette on Thursday profiled Joe Cristina, founder of the Los Angeles-based Children Affected by AIDS Foundation. According to the Post-Gazette, Cristina founded CAAF in 1993 with the support of the toy company Mattel, where he was an executive, as a way to "channel" the "energy and support" he received after being diagnosed with HIV.
The U.S. Drug Enforcement Administration (DEA) had to resort to its emergency powers this Wednesday to ban K2 and other "fake pot" products that mimic the effects of marijuana. As of now it is illegal to possess or sell the five chemicals used to make the products for at least one year. The agency and the Department of Health and Human Services will further debate whether the chemicals should be permanently added to the federal list of controlled substances considered unsafe, highly abused and without medical use.
› Verified 4 days ago